Literature DB >> 27357454

[Provision of outpatient specialist care for mental disorders : Minor regional differences in treatment needs, major regional differences in availability].

F Jacobi1, M Becker2, J Bretschneider2, S Müllender2, J Thom2, U Hapke3, W Maier4,5.   

Abstract

BACKGROUND: Due to the high burden attributed to mental disorders, an important purpose of a general healthcare system is to provide comprehensive medical specialist care that is both locally available and in line with demand; however, the density of outpatient physicians and psychotherapists significantly varies between regions in Germany. To verify if these variations reflect regional variations of morbidity rates, routine data of statutory health insurance companies are analyzed on a regular basis. But these administrative data directly depend on the actual regional health care supply. Hence, independent epidemiological data on prevalence rates of mental disorders could be a valuable supplement.
METHODS: Analyses are based on prevalence rates of the representative epidemiological German health interview and examination survey and its mental health module (DEGS1-MH) as well as supplemental data from the German national and regional associations of statutory health insurance physicians. The associations between prevalence rates and density of outpatient physicians and psychotherapists were computed for the DEGS sample points, representing 139 different German districts. Transregional care provision for neighboring regions was taken into account.
RESULTS: There were neither significant associations of regional density of outpatient physicians and psychotherapists with prevalence rates of mental disorders in general nor with prevalence rates of severe mental disorders; however, taking into account transregional care provision for neighboring regions the huge variability of provider density decreases. DISCUSSION: The regional inequality of physician and psychotherapist density cannot be explained by regional differences in treatment needs. The results indicate potential improvements in healthcare provision for mental disorders in Germany through the adaptation to actual morbidity rates; however, the definition of treatment needs in mental disorders requires further evaluation.

Entities:  

Keywords:  Mental health care; Morbidity; Physician density; Regional differences; Treatment needs

Mesh:

Year:  2016        PMID: 27357454     DOI: 10.1007/s00115-016-0147-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  15 in total

1.  [Data linkage of primary and secondary data: a gain for small-area health-care analysis?].

Authors:  E Swart; C Stallmann; J Powietzka; S March
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2014-02       Impact factor: 1.513

2.  [Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)].

Authors:  F Jacobi; M Höfler; J Strehle; S Mack; A Gerschler; L Scholl; M A Busch; U Maske; U Hapke; W Gaebel; W Maier; M Wagner; J Zielasek; H-U Wittchen
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

3.  [Disease versus disorder. Medical and socio-environmental aspects of mental suffering].

Authors:  A Heinz
Journal:  Nervenarzt       Date:  2015-01       Impact factor: 1.214

Review 4.  The size and burden of mental disorders and other disorders of the brain in Europe 2010.

Authors:  H U Wittchen; F Jacobi; J Rehm; A Gustavsson; M Svensson; B Jönsson; J Olesen; C Allgulander; J Alonso; C Faravelli; L Fratiglioni; P Jennum; R Lieb; A Maercker; J van Os; M Preisig; L Salvador-Carulla; R Simon; H-C Steinhausen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09       Impact factor: 4.600

5.  [Health related quality of life in adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  U Ellert; B M Kurth
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

6.  [Utilization of outpatient and inpatient health services in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  P Rattay; H Butschalowsky; A Rommel; F Prütz; S Jordan; E Nowossadeck; O Domanska; P Kamtsiuris
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

7.  Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data.

Authors:  Anke Bramesfeld; Thomas Grobe; Friedrich Wilhelm Schwartz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-19       Impact factor: 4.328

8.  Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH).

Authors:  Frank Jacobi; Michael Höfler; Jens Siegert; Simon Mack; Anja Gerschler; Lucie Scholl; Markus A Busch; Ulfert Hapke; Ulrike Maske; Ingeburg Seiffert; Wolfgang Gaebel; Wolfgang Maier; Michael Wagner; Jürgen Zielasek; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2014-04-11       Impact factor: 4.035

9.  Urbanicity, social adversity and psychosis.

Authors:  Andreas Heinz; Lorenz Deserno; Ulrich Reininghaus
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

10.  Current major depressive syndrome measured with the Patient Health Questionnaire-9 (PHQ-9) and the Composite International Diagnostic Interview (CIDI): results from a cross-sectional population-based study of adults in Germany.

Authors:  Ulrike E Maske; Markus A Busch; Frank Jacobi; Katja Beesdo-Baum; Ingeburg Seiffert; Hans-Ulrich Wittchen; Steffi Riedel-Heller; Ulfert Hapke
Journal:  BMC Psychiatry       Date:  2015-04-10       Impact factor: 3.630

View more
  7 in total

1.  [Epidemic of depression? : Development of prevalence and help-seeking behaviour].

Authors:  Julia Nübel; Susanne Müllender; Ulfert Hapke; Frank Jacobi
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

2.  Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims data.

Authors:  Christoph J Wagner; Charalabos Markos Dintsios; Florian G Metzger; Helmut L'Hoest; Ursula Marschall; Bjoern Stollenwerk; Stephanie Stock
Journal:  Int J Methods Psychiatr Res       Date:  2018-02-15       Impact factor: 4.035

3.  Time trends in depression prevalence and health-related correlates: results from population-based surveys in Germany 1997-1999 vs. 2009-2012.

Authors:  Julia Bretschneider; Silke Janitza; Frank Jacobi; Julia Thom; Ulfert Hapke; Tobias Kurth; Ulrike E Maske
Journal:  BMC Psychiatry       Date:  2018-12-20       Impact factor: 3.630

Review 4.  [Disease burden of borderline personality disorder: cost of illness, somatic comorbidity and mortality].

Authors:  Frank Jacobi; Raphaela Grafiadeli; Hannah Volkmann; Isabella Schneider
Journal:  Nervenarzt       Date:  2021-06-07       Impact factor: 1.214

5.  Prevention of Common Mental Disorders in Employees. Perspectives on Collaboration from Three Health Care Professions.

Authors:  Eva Rothermund; Martina Michaelis; Marc N Jarczok; Elisabeth M Balint; Rahna Lange; Stephan Zipfel; Harald Gündel; Monika A Rieger; Florian Junne
Journal:  Int J Environ Res Public Health       Date:  2018-02-06       Impact factor: 3.390

6.  Persistent depressive disorder across the adult lifespan: results from clinical and population-based surveys in Germany.

Authors:  Julia Nübel; Anne Guhn; Susanne Müllender; Hong Duyen Le; Caroline Cohrdes; Stephan Köhler
Journal:  BMC Psychiatry       Date:  2020-02-10       Impact factor: 3.630

Review 7.  [Cross-sectoral therapeutic concepts and innovative technologies: new opportunities for the treatment of patients with mental disorders].

Authors:  Dusan Hirjak; Ulrich Reininghaus; Urs Braun; Markus Sack; Heike Tost; Andreas Meyer-Lindenberg
Journal:  Nervenarzt       Date:  2021-03-05       Impact factor: 1.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.